Neuropace
NPCE
NPCE
54 hedge funds and large institutions have $176M invested in Neuropace in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 19 increasing their positions, 13 reducing their positions, and 5 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more funds holding
Funds holding: →
13% more capital invested
Capital invested by funds: $156M → $176M (+$20.2M)
10.51% less ownership
Funds ownership: 57.65% → 47.15% (-11%)
Holders
54
Holding in Top 10
2
Calls
$381K
Puts
$99K
Top Buyers
| 1 | +$5.72M | |
| 2 | +$2.13M | |
| 3 | +$1.85M | |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$997K |
| 5 |
Acadian Asset Management
Boston,
Massachusetts
|
+$621K |
Top Sellers
| 1 | -$32.2M | |
| 2 | -$5.22M | |
| 3 | -$2.18M | |
| 4 |
KLC
Kent Lake Capital
Reno,
Nevada
|
-$361K |
| 5 |
6CM
683 Capital Management
New York
|
-$257K |